avapro has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, T | 1 |
| Xie, Y | 1 |
| Hou, X | 1 |
| Bai, W | 1 |
| Li, X | 1 |
| Liu, Z | 1 |
| Man, Q | 1 |
| Sun, J | 1 |
| Fu, D | 1 |
| Yan, J | 1 |
| Zhang, Z | 1 |
| Wang, Y | 1 |
| Wang, H | 1 |
| Jiang, W | 1 |
| Gao, S | 1 |
| Zhao, T | 1 |
| Chang, A | 1 |
| Wang, X | 1 |
| Sun, H | 1 |
| Zhang, X | 1 |
| Yang, S | 1 |
| Huang, C | 1 |
| Hao, J | 1 |
| Liu, J | 1 |
1 other study available for avapro and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Models, Animal; Gemcitabine; Humans | 2023 |